December 17, 2018 — 2018 is quickly fading into history. All in all, it’s been a year of some remarkable progress in obesity and health. Much of it is steady and encouraging. More healthcare providers building skill in obesity care. Less explicit weight bias. More options and a little less misinformation about obesity. Those are some of the good […]
December 2, 2018 — In the UK, the National Health Service (NHS) is coming to terms with the impact of obesity and diabetes. Chief executive Simon Stevens says: The NHS is now going to be ramping up practical action to support hundreds of thousands people and avoid obesity-induced heart attacks, strokes, cancers and type 2 diabetes. Because what’s good […]
November 29, 2018 — Health reporters have a news flash for us. Soda is the worst! All those other sugary foods? Not so bad, say the headlines. For diabetes risk, soda is the thing to fear. A Very Nuanced Study vs Sensational Headlines Why are we suddenly awash in such headlines? A study in the BMJ is at the […]
October 17, 2018 — Yesterday, JAMA published five articles about bariatric surgery. Two new research papers. Three editorials. Taken together they present a picture of the compelling benefits of bariatric surgery in patients with both obesity and diabetes. But they also point to the gap between the reality of bariatric surgery and how we’re dealing with it. Cutting the […]
August 3, 2018 — Many publications lately have documented the possibility for obesity care and resulting weight loss to reverse type 2 diabetes. But it’s hardly a sure thing. So the question remains, how does this happen in some patients and not in others? A new study in Cell Metabolism offers some clues. Digging into Diabetes Remissions Late last […]
June 30, 2018 — New research in Lancet Planetary Health finds that air pollution is adding to the global burden of diabetes. In fact, researchers estimate that it contributed to 3.2 million new cases of type 2 diabetes in 2016 alone. Published yesterday, the study suggest that cuts in air pollution might help reverse global trends toward a crushing […]
June 16, 2018 — Yesterday, Michael Schwartz delivered this year’s Blackburn Lecture in Obesity Medicine. The lecture series honors both the memory of George Blackburn and individuals who have made extraordinary contributions to the science of obesity. Schwartz painted a remarkably clear picture of some complex neuroscience. Evidence is accumulating to describe the brain’s control center for diabetes and […]
March 24, 2018 — Maybe it’s not on the tip of every tongue. But serotonin is a bit more familiar than most neurotransmitters. Most people think of it as a “happy hormone” for the central nervous system that becomes depleted in a state of depression. However, The GI system has far more of it than the CNS. And now, […]
March 8, 2018 — Recent news makes it clear. You can be sure that relentless change lies ahead for type 2 diabetes care. The American College of Physicians (ACP, representing 152,000 internists) is fighting with the American Diabetes Association and other experts over the standard of care. And Scandinavian researchers have found that we might do well to split […]
February 23, 2018 — Wachet auf! As if the clues were not already present, an announcement yesterday makes it plain. Competitors in the sleepy diabesity market had best wake up. The first ever oral GLP-1 agonist for diabetes and obesity – semaglutide – is looking good in clinical trials. That means everyone else had better get serious about innovation. Or risk becoming […]
